Boutique Regulatory Edge Dunn Regulatory Associates is a small to mid-sized regulatory services firm (11-50 employees, estimated revenue of 10-25 million) offering focused regulatory strategy, US Agent services, IND maintenance, and CTD/IB management—ideal for mid-market biopharma, devices, or cosmetics sponsors needing nimble, cost-effective support.

Full Lifecycle Capabilities They provide end-to-end regulatory support across strategy, document preparation, expedited pathways, integrated development plans, and FDA/EU negotiations, enabling lifecycle management from development through submission—present a compelling upsell to sponsors seeking a one-stop regulatory partner.

Expedited Pathways Focus Expertise in leveraging expedited regulatory pathways such as Breakthrough therapy positions Dunn to attract clients aiming for faster time-to-market, premium pricing, or prioritization; opportunities to cross-sell global strategy and EU submissions.

DC Proximity Advantage Headquartered in Oakton, Virginia, near Washington DC, offering potential advantages in FDA and regulatory engagement; pitch as the preferred US Agent and regulatory liaison for clients with US INDs and cross-border submissions, reducing cycle times.

Midmarket Growth Fit In a landscape with large CROs, Dunn can differentiate by personalized service and agility, targeting biotech startups and mid-sized pharma with budget-conscious, outcome-focused engagements; potential to expand into cosmetics/devices regulatory work and to scale through a retainer-based or project-based model.